Equities

Medical Properties Trust Inc

Medical Properties Trust Inc

Actions
  • Price (EUR)15.95
  • Today's Change-0.254 / -1.57%
  • Shares traded2.32k
  • 1 Year change35.71%
  • Beta--
Data delayed at least 15 minutes, as of Jun 17 2019.
More ▼

Profile data is unavailable for this security.

About the company

Medical Properties Trust, Inc. is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company's segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants. The Company conducts its operations through MPT Operating Partnership, L.P. The Company acquires and develops healthcare facilities, and leases the facilities to healthcare operating companies under long-term net leases. The Company makes mortgage loans to healthcare operators collateralized by their real estate assets. As of February 24, 2017, the Company's portfolio consisted of 232 properties, including 215 facilities (of the 220 facilities that it owns) were leased to 30 tenants, five were under development, and the remaining assets were in the form of mortgage loans to four operators.

  • Revenue in USD (TTM)759.93m
  • Net income in USD997.94m
  • Incorporated2003
  • Employees77.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MPW:NYQ since
announced
Transaction
value
Healthscope Ltd-Hospital Properties(11)Deal completed31 Jan 201931 Jan 2019Deal completed0.72%859.00m
Data delayed at least 15 minutes, as of Jun 17 2019 21:02 BST.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.